4.8 Article

miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1

Journal

ONCOGENE
Volume 33, Issue 25, Pages 3267-3276

Publisher

SPRINGERNATURE
DOI: 10.1038/onc.2013.297

Keywords

miR-508-5p; gastric cancer; drug resistance; ABCB1; ZNRD1

Funding

  1. [81030044]
  2. [2010CB529300]
  3. [2010CB529305]
  4. [2010CB529306]
  5. [2010CB529302]
  6. [NSFC-81120108005]
  7. [81172096]
  8. [863-2012AA02A203]
  9. [8632012AA02A504]

Ask authors/readers for more resources

Multidrug resistance (MDR) is usually correlated with the poor prognosis of gastric cancer. In this study, we revealed a total of 11 microRNAs (miRNA) that regulated MDR of gastric cancer via high-throughput functional screening, and miR-508-5p reversed MDR most efficiently among these candidate miRNAs. The overexpression of miR-508-5p was sufficient to reverse cancer cell resistance to multiple chemotherapeutics in vitro and sensitize tumours to chemotherapy in vivo. Further studies showed that miR-508-5p could directly target the 3'-untranslated regions of ABCB1 and Zinc ribbon domain-containing 1 (ZNRD1), and suppress their expression at the mRNA and protein levels. Meanwhile, the suppression of ZNRD1 led to a decrease in ABCB1. These findings suggest that a miR-508-5p/ZNRD1/ABCB1 regulatory loop has a critical role in MDR in gastric cancer. In addition, miR-508-5p could be used as a prognostic factor for overall survival in gastric cancer. These data reveal an important role for miR-508-5p in the regulation of MDR in gastric cancer, and suggest the potential application of miR-508-5p in drug resistance prediction and treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available